Abstract
Introduction
CD45 is a transmembrane protein tyrosine phosphatase abundantly present on the cell surface of all nucleated hematopoietic cells. This protein exists in several isoforms due to alternative splicing of four of its exons (for reviews see 1,2). Studies with CD45" mutant cell lines that were antigen receptor "signaling deficient showed that expression of CD45 is a prerequisite for transmembrane signal transduction upon triggering of the TCR (3, 4) as well as the B cell antigen receptor (5) . It was further demonstrated that CD45 dephosphorylates specifically negative regulatory tyrosine residues of src family protein tyrosine kinases, an event that results in increased kinase activity in T cells (6) (7) (8) (9) and B cells (5, 10, 11) . The disruption of the CD45 gene underlined clearly the essential role of this phosphatase in T lymphocyte development and B cell function, since it resulted in a drastic reduction of mature single-positive thymocyte numbers and mature B lymphocytes with signaling-deficient antigen receptors (12) .
Protein phosphorylation is an important mechanism of transducing signals in eukaryotic cells. It has been proposed that a resting cell is maintained below a threshold for signaling through a balance between opposing dephosphorylation and phosphorylation reactions (13) . In fact, chemical inactivation of phosphatases in Jurkat cells leads to IL-2 production without TCR triggering (14) , which indicates that the cell has to regulate both opposing activities tightly to keep them in balance.
Little is yet known about the regulation of CD45-phosphatase activity. It has been suggested that the different isoforms of CD45 could interact with different ligands and become thereby differentially activated (for review see 2). When mouse thymocytes were previously investigated for expression of certain isoforms that might correlate to positive or negative selection events, not all analyzed thymocytes (only 1-3%) expressed specific isoforms (15) .
Therefore, in the present study we used three different CD45 pan-isoform-specific reagents together with CD4, CD8 and CD3, heat stable antigen (HSA) or CD69 as thymocyte markers as well as IgM, IgD, CD19 or B220 as B lymphocyte markers and extensively analyzed CD45 expression (regardless of isoforms) in various thymocyte subsets as well as during B cell development.
In clear contrast to earlier reports (16), we demonstrate in this study that there is an extremely tight correlation between CD45 expression levels and positive selection events in the thymus. More Data are derived from the same analysis as shown in Fig. 1 . Similar to Fig. 1 , six gates were set to cover the developmental transition between immature CD4 + CD8 + and mature CD4 + CD8~ T cells. The mean relative fluorescence intensity of CD45, CD3 and CD4 of the various subpopulations is shown.
cell maturation. We discuss the implications of these findings with respect to TCR and B cell receptor expression levels during lymphocyte development.
Methods

Mice
B6.SJL (Ly-5 a
) and C56BL/6 mice were purchased from Jackson Laboratories (Bar Harbor, ME) or IFFA Credo (Orleans, France) respectively. TCR transgenic mice, with a hemagglutinin-specific, l-E d -restricted TCR, were as described before and crossed to a recombination activating gene negative (RAG-2^-) background (17 (23) . Anti-CD4-phycoerythrin (Becton Dickinson, Plymouth, UK), anti-CD8-Red613 (Gibco/lmmunoselect/BRL, Grand Island, NY), anti-lgD (clone 217-170; PharMingen, San Diego, CA), anti-IgM (clone AF6-78; PharMingen), RA3-6B2 (anti-CD45, B220 isoform; PharMingen) and anti-CD45-FITC (clone 30F11.1, specific for all CD45 isoforms; PharMingen) conjugates were obtained commercially. With these and the second step reagent streptavidin-allophycocyanin (APC; Molecular Probes, Eugene, OR) four color flow-cytometry was performed on a FACStar" 1 " (Becton Dickinson) instrument equipped appropriately.
Single cell preparation, staining and FACS analysis were done according to standard procedures.
Results
In order to investigate the expression of CD45 on thymocytes of B6.SJL mice that were homozygous for one of the CD45 alleles (Ly-5 a ), we performed four-color flow cytometric analysis with mAb specific for CD4, CD8, CD45 and a fourth marker (CD3, CD69 or HSA respectively) (Fig. 1) . We first analyzed the thymocytes according to their CD4 and CD8 expression and gated them in distinct developmental stages between double-positive (DP) and single-positive (SP) thymocytes (see Fig. 1, gates 1-9 ). We further analyzed the cells in gates 1-9 according to their expression of CD45 versus either CD3, CD69 or HSA. Figure 1 shows that the expression levels of CD45 increase during maturation of thymocytes ( When we compared CD69 and CD45 ( Fig. 1) we observed the expected transient up-regulation of CD69 (26) by thymocytes on their way to mature CD4 + SP or CD8 + SP cells. This transient up-regulation of CD69 takes place at the same stage as CD45 up-regulation. With further maturation CD69 is downregulated again, while CD45 expression levels remain high (Fig. 1, gates 5 and 9 ). Immature CD8 + SP thymocytes remain CD45 low (see lower right dot-plot corresponding to gate 9).
We then analyzed the expression of CD45 in the context of HSA. As described previously, immature thymocytes express high levels of HSA and lose this marker on their way to mature SP cells (27) . According to Fig. 1 (right lower panel) practically all of the more mature thymocytes became CD45 h ' 9h before they started to lose HSA expression.
Quantitative analysis of three surface markers shows that CD4 levels do not change, CD3 is up-regulated -12 times and CD45 levels are increased 2-fold during thymocyte maturation as shown in Table 1 .
In order to see whether this event is dependent on positive selection, we repeated the experiments in RAG-2~'~ TCRtransgenic mice that can or cannot positively select immature thymocytes. As previously described (17) , in the I-E d+ TCRtransgenic RAG-2"'" mice, positive selection leads to the presence of CD4 + SP and CD8 + SP mature thymocytes ( be detected (Fig. 2) . We gated on CD4 + CD8 + DP, CD4+ SP or CD8 + SP thymocytes (gates 1, 2 and 3), and analyzed them for CD45 versus CD3, CD69 and HSA. In case of I-E d+ TCR-transgenic RAG-2"'"" mice we observed the same correlation between these markers as described above: CD45 is up-regulated during positive selection on thymocytes (Fig.  2) . In contrast, thymocytes from I-E d "TCR-transgenic RAG-2^" mice that cannot positively select with this TCR remain CD45 l0W (Fig. 2) . Thus CD45 up-regulation is dependent on positive selection events.
To test whether CD45 up-regulation is allele-specific we compared I-E d+ and I-E d " TCR-transgenic RAG-2~'~ mice that were homozygous for the CD45 allele Ly-5 b . As shown in Fig.  3 , we obtained similar results as in Ly-5a mice. Apparently CD45 up-regulation upon positive selection is a general phenomenon, not restricted to a particular allele.
While the majority of thymocytes and activated T cells express different low mol. wt isoforms of CD45, B220, a high molecular isoform of CD45, has been routinely used as a marker for all B lineage cells (1, 28) . We were interested if the observed CD45 up-regulation during T cell maturation could similarly be detected with a pan-isoform CD45 specific mAb on developing B cells in the bone marrow. To this end we analyzed bone marrow cells as shown in Fig. 4 . To concentrate on B lineage cells, we first gated on B220 + cells (data not shown). According to their surface IgM and IgD expression we divided these into four stages corresponding to gates 1-4: IgM/lgD double negative (gate 1), lgM l0W SP (gate 2), i gM high SP and |gM hi gh/|gD'°w DP (gate3), and IgM/lgD DP (gate 4), reflecting the normal B cell developmental pathway. When these four populations were analyzed for CD45 expression levels, we found an up-regulation of CD45 (see histograms in Fig. 4 ) tightly linked to surface Ig up-regulation and B cell maturation.
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Discussion
Earlier studies have shown that it is difficult to define rules for the regulation of CD45 isoform expression on thymocytes, since only minimal populations (1-3%) express specific isoforms (CD45RA and CD45RB h '9 h ) that occur during positive or negative selection in the thymus (15) . Since a much higher percentage of thymocytes are positively selected in normal and TCR-transgenic mice but do not express or up-regulate certain CD45 isoforms, we investigated the overall expression levels of CD45 on thymocytes with pan-CD45 antibodies to see if isoform-independent regulation might occur. Using fourcolor flow cytometry we analyzed thymocytes from normal and TCR-transgenic mice and compared CD45 expression levels with other more commonly used thymocyte markers like CD3, CD69 and HSA. As measured with three different mAb specific for all isoforms of CD45, we describe here that CD45 expression levels are lower on CD4 + CD8 + DP thymocytes, but increase when these cells mature to the CD4+ SP or CD8 + SP stage. The CD45 up-regulation occurs simultaneously with an increase of TCR-CD3 levels and one might argue that the CD45 phosphatase levels are increased because of an ongoing increase of TCR-CD3 levels in order to regulate signals received during thymocyte positive selection. Nearly all (>90%) thymocytes followed this rule.
Interestingly, during B cell development, the CD45 isoform B220 shows a similar shift in surface expression (29) . However, as yet undetected was the general, isoform-independent upregulation of CD45 expression when B cells start to express Ig, as shown in this study.
These findings indicate that the total CD45 levels (regardless of its isoforms) may be important in developing lymphocytes to regulate signal transduction activity during lymphocyte maturation.
